Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human... see more

TSXV:CZO - Post Discussion

Ceapro Inc > No one wants to deal with Gilles….
View:
Post by hoffbag on Feb 04, 2023 10:40am

No one wants to deal with Gilles….

Why didn't Ceapro's Trojan Horse get bought by Lallemand. 

Lallemand goes to Norway to buy Biotec BetaGlucans?Must have been their superior WOUND HEALING GEL that is actually on the market.

Comment by Ciao on Feb 04, 2023 12:21pm
What are the sales for the Woulgan gel? Soluable beta glucan doesn't sound unique or a market disruptor. You have a yeast company buying a wound healing gel to complement their business. Good to know that a delivery system using beta glucan as a carrier for a bioactive like ipubrofen would likely be more effective.A pharma company finding an additional application for a current drug would ...more  
Comment by Ciao on Feb 04, 2023 12:26pm
Results for the animal wound healing project by the Angiogenesis Foundation is using AV and is near completion with results due in Q2 this year.
Comment by prophetoffactz on Feb 04, 2023 1:52pm
And we will see if CZO has built on the PGX-ibuprofin results.  Ceapro Inc. Announces Publication of Positive Results for a PGX Processed Drug Delivery System for Accelerated Burn Wound Healing V.CZO | June 15, 2020 – Results from successful drug-impregnation of PGX liquid processed alginate hydrogel scaffolds further bolsters Ceapro’s ...more  
Comment by Ciao on Feb 04, 2023 3:30pm
Interesting video from Woulglan which supports the work at McMaster with the re-programming of macrophages in resolving inflammation. Having AV impregnated in PGX BG definitely looks like a potential evolutionary improvement to their product. {^youtubevideo|(width)425|(height)264|(rel)False|(url)https://www.youtube.com/watch?v=PnZkNzGxJX0&t=87s&ab_channel=WoulganBBG|(fs)True|(loop)False ...more  
Comment by laurencelefou on Feb 04, 2023 4:46pm
https://woulgan.com/
Comment by laurencelefou on Feb 04, 2023 4:49pm
https://arcticzymes.com/arcticzymes-technologies-divests-biotec-betaglucans-subsidiary-to-lallemand/
Comment by prophetoffactz on Feb 04, 2023 2:03pm
The study is not only just CZO's avenanthramides for wound healing. It is also CZO's beta glucan for wound healing. CZO's beta glucan was of interest for wound healing in 2005:  "Interestingly, the glucan penetrates in the same way that waterpenetrates a brick wall--it does not go through the brick, it goesthrough the concrete binding the bricks together," says Redmond. ...more  
Comment by hoffbag on Feb 04, 2023 2:52pm
Wonder why no one is interested in Ceapro.....I guess it's because the industry players don't get it but the investors web surfing in mama's basement do. 
Comment by prophetoffactz on Feb 04, 2023 7:02pm
"Wonder why no one is interested in Ceapro.....I guess it's because the industry players don't get it..." Gilles said Symrise likes what CZO is doing and gave the example of a second-generation Aveeno with CoQ10. As the President and CEO of Roche Canada for 22 years it is hard to find a bigger name in Canadian pharma than Ronnie Miller who has been called an icon in the Canadian ...more  
Comment by boazklinghorn on Feb 05, 2023 12:43pm
I think you have it exactly backwards, it isnt that no one wants to work with Gilles its that Gilles doesnt want to work with anyone. He has the perfect job running a company that makes 2 products and sells them to one buyer. The base business has been on autopilot for years. I did ask Gilles one question at one of Jeneens earlier stupid forums and that was "What are you doing to drive sales ...more  
Comment by prophetoffactz on Feb 05, 2023 5:34pm
boazklinghorn, "I think you have it exactly backwards, it isnt that no one wants to work with Gilles its that Gilles doesnt want to work with anyone." Who are we to believe? Stockhouse poster boazklinghorn who says Gilles doesn't want to work with anyone or C$20 billion market cap Symrise who's complemented CZO, on the record, for its long-standing relationship in product ...more  
Comment by boazklinghorn on Feb 06, 2023 11:51am
LOL Proph, spoken like a true academic who has never made an entrepenurial dollar in his life. Give me one good idea and a great communicator over a lab full off Phds everyday of the week. 
Comment by boazklinghorn on Feb 06, 2023 12:49pm
Researchers with letters after thier names are a dime a dozen. Every successful company has them by the hundreds, but a visionary marketer is worth their wieght in gold. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities